Pediatric psychopharmacology: current status.
D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001008:Anxiety Disorders / Q000188:drug therapy; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D002657:Child Development; D002675:Child, Preschool; D002707:Chlordiazepoxide / Q000494:pharmacology; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs; D002707:Chlordiazepoxide